Purified anti-human SSEA-4 330401 from BioLegend

Product Specs
ItemPurified anti-human SSEA-4
CompanyBioLegend
Price Pricing Info Supplier Page View Company Product Page
Catalog Number330401
IsotypeIgG3, Kappa
HostMouse
FormatPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide with stabilizer
CloneMC-813-70
ApplicationsFlow Cytometry (FC), Immunocytochemistry (ICC), Immunohistochemistry (IHC)-P, Immunohistochemistry (IHC)-F, ELISA
Quantity25 µg
Conjugate/TagUnconjugated
ReactivityHuman
Concentration0.50 mg/mL
ImmunogenHuman embryonic carcinoma cell line 2102Ep
Antibody TypePrimary
ClonalityMonoclonal
TargetSSEA-4

Add to Compare List

BioLegend

8999 BioLegend Way

San Diego, California 92121

United States

Phone: 1-877-246-5343 Toll-Free, USA & Canada
1-858-768-5800 International
Fax: 1-877-455-9587

Company Profile

Website: biolegend.com

(1) Synthetic genetic circuits to uncover the OCT4 trajectories of successful reprogramming of human fibroblastsScience AdvancesDecember 1, 2023Katherine Ilia, Nika Shakiba, Trevor Bingham, Ross D. Jones, Michael M. Kaminski, Eliezer Aravera, Simone Bruno, Sebastian Palacios, Ron Weiss, James J. Collins, et al.staining solution containing 1:2000 mouse immunoglobulin G (IgG) anti-human SSEA4 antibody (BioLegend, #330402) and 1.2:2000 mouse IgM anti-human TRA1-60 antibody (BioLegend, #330602). Then, we washed the cells

(2) Hypoxia enhances IPF mesenchymal progenitor cell fibrogenicity via the lactate/GPR81/HIF1α pathwayJCI InsightFebruary 22, 2023Libang Yang, Adam Gilbertsen, Hong Xia, Alexey Benyumov, Karen A Smith, Jeremy A Herrera, Emilian Racila, Peter B. Bitterman, Craig A. Henkeantibody (1:500) (Ab15086, Abcam), and anti–human SSEA4 antibody (1:100) (clone MC-813-70, catalog 330402, BioLegend). Specimens were cover-slipped with a Prolong Antifade Kit (Invitrogen/Molecular Probes)

(3) Generation of human induced pluripotent stem cell line EURACi006-A and its isogenic gene-corrected line EURACi006-A-1 from an arrhythmogenic cardiomyopathy patient carrying the c.1643delG PKP2 mutationStem cell researchJuly 1, 2021Meraviglia V, Ganesh S, Arendzen CH, Freund C, Sommariva E, Rossini A, Bellin M.

(4) A CD44/Brg1 nuclear complex conveys mesenchymal progenitor cells with enhanced fibrogenicity in idiopathic pulmonary fibrosisJCI InsightMay 10, 2021Libang Yang, Hong Xia, Karen A. Smith, Adam Gilbertsen, Daniel Beisang, Jonathan Kuo, Peter B. Bitterman, Craig A. Henke(Spring Bioscience, catalog M3370); and anti-human SSEA4 antibody (1:100) (BioLegend, clone MC-813-70, catalog 330402). Specimens were cover-slipped with a Prolong Antifade Kit (Invitrogen Molecular Probes, Thermo Fisher

(5) Generation of three human induced pluripotent stem cell lines, LUMCi024-A, LUMCi025-A, and LUMCi026-A, from two patients with combined oxidative phosphorylation deficiency 8 and a related controlStem cell researchMay 1, 2021van Helden RWJ, Birket MJ, Freund C, Arendzen CH, Mikkers HM, Orlova V, de Coo RI, Mummery CL, Bellin M.

(6) Generation of two gene edited iPSC-lines carrying a DOX-inducible NGN2 expression cassette with and without GFP in the AAVS1 locusStem cell researchApril 1, 2021Schmid B, Holst B, Poulsen U, Jørring I, Clausen C, Rasmussen M, Mau-Holzmann UA, Steeg R, Nuthall H, Ebneth A, et al.

(7) Reprogramming competence of OCT factors is determined by transactivation domainsScience advancesSeptember 1, 2020Kim KP, Wu Y, Yoon J, Adachi K, Wu G, Velychko S, MacCarthy CM, Shin B, Röpke A, Arauzo-Bravo MJ, et al.Millipore), mouse monoclonal anti–TRA-1-81 (1:100, MAB4381; Millipore), mouse monoclonal anti–SSEA-4 (1:100, 330402; BioLegend), rabbit monoclonal anti-NANOG (1:1000, 5232; Cell Signaling Technology), rabbit monoclonal

(8) Single-cell RNA sequencing reveals that lung mesenchymal progenitor cells in IPF exhibit pathological features early in their differentiation trajectoryScientific reportsJuly 7, 2020Beisang DJ, Smith K, Yang L, Benyumov A, Gilbertsen A, Herrera J, Lock E, Racila E, Forster C, Sandri BJ, et al.were stained with Hematoxylin-Eosin, or probed with the following antibodies: anti-SSEA4 (Biolegend, #330401, 1:50), anti-CD44 (Abcam, ab101531, 1:500), anti-MARCKS (Novus, NB110-58875SS, 1:500), anti-pro-collagen

(9) Generation of a human iPSC line (MPIi006-A) from a patient with Pelizaeus-Merzbacher diseaseStem cell researchJuly 1, 2020Kim KP, Yoon J, Shin B, Röpke A, Han DW, Schöler HR.

(10) iPSC-Based Modeling of RAG2 Severe Combined Immunodeficiency Reveals Multiple T Cell Developmental ArrestsStem cell reportsFebruary 11, 2020Themeli M, Chhatta A, Boersma H, Prins HJ, Cordes M, de Wilt E, Farahani AS, Vandekerckhove B, van der Burg M, Hoeben RC, et al.recognizing OCT3/4 (1:100; Santa Cruz Biotechnology, cat. no. sc-5279), SSEA4 (1:30; Biolegend, cat. no. 330402), TRA1-81 (1:125; Biolegend, cat. no. 330702), and NANOG (1:500; R&D Systems, cat. no. 963488) and Alexa

(11) Generation of genetically matched hiPSC lines from two mosaic facioscapulohumeral dystrophy type 1 patientsStem cell researchOctober 1, 2019van der Wal E, den Hamer B, van der Vliet PJ, Tok M, Brands T, Eussen B, Lemmers RJLF, Freund C, de Klein A, Buijsen RAM, et al.

(12) Generation of a FMR1 homozygous knockout human embryonic stem cell line (WAe009-A-16) by CRISPR/Cas9 editingStem cell researchAugust 1, 2019Giri S, Purushottam M, Viswanath B, Muddashetty RS.

(13) Generation of 5 induced pluripotent stem cell lines, LUMCi007-A and B and LUMCi008-A, B and C, from 2 patients with Huntington diseaseStem cell researchAugust 1, 2019van der Graaf LM, Gardiner SL, Tok M, Brands T, Boogaard MW, Pepers BA, Eussen B, de Klein A, Aziz NA, Freund C, et al.

(14) Generation of two isogenic iPSC lines with either a heterozygous or a homozygous E280A mutation in the PSEN1 geneStem cell researchMarch 1, 2019Frederiksen HR, Holst B, Mau-Holzmann UA, Freude K, Schmid B.

(15) Generation of two iPSC lines with either a heterozygous V717I or a heterozygous KM670/671NL mutation in the APP geneStem cell researchJanuary 1, 2019Frederiksen HR, Holst B, Ramakrishna S, Muddashetty R, Schmid B, Freude K.

(16) Generation of 3 human induced pluripotent stem cell lines LUMCi005-A, B and C from a Hereditary Cerebral Hemorrhage with Amyloidosis-Dutch type patientStem cell researchJanuary 1, 2019Daoutsali E, Buijsen RAM, van de Pas S, Jong A', Mikkers H, Brands T, Eussen B, de Klein A, van der Graaf LM, Pepers BA, et al.

(17) Generation of nine induced pluripotent stem cell lines as an ethnic diversity panelStem cell researchAugust 1, 2018Gao X, Yourick JJ, Sprando RL.

(18) Generation of 3 spinocerebellar ataxia type 1 (SCA1) patient-derived induced pluripotent stem cell lines LUMCi002-A, B, and C and 2 unaffected sibling control induced pluripotent stem cell lines LUMCi003-A and BStem cell researchMay 1, 2018Buijsen RAM, Gardiner SL, Bouma MJ, van der Graaf LM, Boogaard MW, Pepers BA, Eussen B, de Klein A, Freund C, van Roon-Mom WMC.

(19) IL-8 mediates idiopathic pulmonary fibrosis mesenchymal progenitor cell fibrogenicityAmerican journal of physiology. Lung cellular and molecular physiologyJanuary 1, 2018Yang L, Herrera J, Gilbertsen A, Xia H, Smith K, Benyumov A, Bitterman PB, Henke CA.(1:200; Cat. No. MAB331100; R&D Systems, Minneapolis, MN), and SSEA4 (1:100; Clone MC-813-70; Cat. No. 330402; Biolegend, San Diego, CA). Sections were rinsed with PBS and placed in biotinylated horse anti-Mouse

(20) In trans paired nicking triggers seamless genome editing without double-stranded DNA cuttingNature communicationsSeptember 22, 2017Chen X, Janssen JM, Liu J, Maggio I, 't Jong AEJ, Mikkers HMM, Gonçalves MAFV.antibodies directed against TRA-1-81 (1:125; Biolegend Cat. #330702), SSEA4 (1:30; Biolegend Cat. #330402), OCT3/4 (1:100; Santa Cruz Biotechnology Cat. #sc-5279); NANOG (1:500; R&D Systems Cat. #963488); AFP

Be the First to Write a Review!

Purified anti-human SSEA-4 from BioLegend

Description

BioLegend

Citations (23)

Reviews

Purified anti-human SSEA-4 from BioLegend

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map